 Soluble interleukin receptor lung cancer indirect marker tumor activity levels soluble interleukin receptor vivo measure immunologic response human tumors total serum assays patients lung cancer diagnosis treatment patients pulmonary benign diseases voluntary healthy subjects Patients lung cancer median value U/ml superior controls U/ml patients noninflammatory benign diseases U/ml infectious pulmonary disorders tuberculosis pneumonia values substance median U/ml diagnosis lung cancer stage disease cell type contrary posttreatment levels receptor status RO subgroup nonsurgical patients RO Patients abnormal levels significant reduction survival patients normal values Measurements useful patients treatment bronchogenic carcinoma prognostication setting new class biologic markers information complementary classic tumor-derived markers